Glenview Capital Management: Portfolio changes for 4Q14


Feb. 27 2015, Updated 12:04 p.m. ET

Glenview Capital Management’s 4Q14 portfolio

Larry Robbins’ Glenview Capital Management was founded in 2000. The fund started as a result of a split between Glenview Funds and Little Arbor Funds.

Robbins makes concentrated bets on large cap stocks. The fund invests in public equity companies and fixed income markets. It uses fundamental analysis to choose stock for its portfolio.

Glenview Capital Management’s fourth quarter 2014 portfolio increased 4.5% to $19.98 billion, from $19.13 billion in the third quarter of 2014. In this series, we’ll take a close look at some of Glenview Capital’s key traded positions during the fourth quarter.

Article continues below advertisement

Glenview Capital’s notable positions in 4Q14

During 4Q14, Glenview Capital initiated a position in Allergan, Inc. (AGN). The fund sold its positions in Citigroup Inc. (C) and Centene Corporation (CNC).

The fund increased its positions in eBay Inc. (EBAY), Mohawk Industries, Inc. (MHK), CBS Corporation (CBS), and Avis Budget Group, Inc. (CAR).

The fund lowered its positions in Crown Castle International Corp. (CCI), HCA Holdings Inc. (HCA), National Oilwell Varco (NOV), and Applied Materials, Inc. (AMAT).

The fund also started positions in Apollo Education Group, Inc. (APOL), and Jarden Corporation (JAH). It sold its positions in LifePoint Hospitals, Inc. (LPNT) and Advance Auto Parts, Inc. (AAP).

The above chart shows the top ten positions the fund held at the end of 4Q14.

In the next part of this series, we’ll look at Glenview Capital Management’s new position in Allergan, Inc. (AGN).

You can gain exposure to Allergan (AGN) by investing in the Health Care Select Sector SPDR ETF (XLV). AGN accounts for 2.58% of XLV.


More From Market Realist